Pharmaceuticals : Shots - Health News Pharmaceuticals

Food and Drug Commissioner Scott Gottlieb tweeted Tuesday that he is ready to implement a right-to-try law "in a way that achieves Congress' intent to promote access and protect patients." Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

Aimovig, a new kind of migraine drug, is injected once a month. The medicine reduced the number of migraines in clinical studies reviewed by the Food and Drug Administration. Amgen/AP hide caption

toggle caption
Amgen/AP

Health and Human Services Secretary Alex Azar talked Friday about the administration's plans to lower drug prices as President Trump looked on in the White House Rose Garden. Chip Somodevilla/Getty Images hide caption

toggle caption
Chip Somodevilla/Getty Images

Maryland's overturned law restricted the price of generic drugs, and had been hailed as a model for other states. It's one of a number of state initiatives designed to combat rapidly rising drug prices. Towfiqu Photography/Getty Images hide caption

toggle caption
Towfiqu Photography/Getty Images

When patients connect online, they often share information that reveals how treatments work in the real world. Roy Scott/Getty Images/Ikon Images hide caption

toggle caption
Roy Scott/Getty Images/Ikon Images
stevecoleimages/Getty Images

Probe Into Generic Drug Price Fixing Set To Widen

  • Download
  • <iframe src="https://www.npr.org/player/embed/590217561/591423244" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Jessica Morris prepares to inject a blood-clotting protein into son Landon's arm at their home in Yuba City, Calif. Heidi de Marco/Kaiser Health News hide caption

toggle caption
Heidi de Marco/Kaiser Health News

Miracle Of Hemophilia Drugs Comes At A Steep Price

  • Download
  • <iframe src="https://www.npr.org/player/embed/589469361/590974657" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Little, Brown and Company

Long-Term Effects Of Psychotropic Drugs Are 'Cloaked In Mystery'

  • Download
  • <iframe src="https://www.npr.org/player/embed/589081018/589238184" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. Ronald Cirillo helps Deborah Hatfield fill out paperwork at a Florida clinic, before running a test to see whether she has hepatitis C. Daylina Miller/Health News Florida hide caption

toggle caption
Daylina Miller/Health News Florida

From Retirement To The Front Lines Of Hepatitis C Treatment

  • Download
  • <iframe src="https://www.npr.org/player/embed/567750728/575168322" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. Scott Gottlieb, Food and Drug Administration commissioner, told Kaiser Health News the incentives intended to spur development of drugs for rare diseases deserve a fresh look. J. Scott Applewhite/AP hide caption

toggle caption
J. Scott Applewhite/AP